RESULTS OF AN OBSERVATIONAL STUDY IN 574 COMMUNITY PHARMACIES IN SPAIN CHARACTERIZING PATIENT PROFILES OF MEN ASKING FOR ERECTILE DYSFUNCTION MEDICATION

Author(s)

Martí B1, Ibañez J2, Machuca M3, Pol-Yanguas E4, Schnetzler G5, Pascual Renedo V61Health Outcomes Research, Pfizer, Spain, 2Ibañez Pharmacy, Barcelona, Barcelona, Spain, 3Machuca Pharmacy, Seville, Seville, Spain, 4Pharmacy, Alicante, Alicante, Spain, 5Pfizer International Operations, Paris, France, 6Pfizer Spain, Madrid, Madrid, Spain

OBJECTIVES: To characterize patient profiles of men asking for an erectile dysfunction (ED) treatment at the pharmacy METHODS: Multi-center, observational, cross-sectional study carried out in community pharmacies in Spain. Each investigator recruited one patient with a prescription for an ED treatment (Rx-group) and one patient that came into the pharmacy without prescription but asking for an ED treatment (Non-Rx group). Study pharmacists completed a questionnaire asking the patient demographic, clinical and behavioral questions including the SHIM (Sexual Health Inventory for Men). RESULTS: A total of 574 pharmacists recruited 1147 patients, whereof 1113 (97%) were included for analysis. Mean age was 58.5 (age range 28-91) years for the Rx-group and 54.8 (age range 21-88) years for the Non- Rx group (p<0.001). There was no statistical difference between the groups regarding weight, BMI, known hypertension, diabetes mellitus, hypercholesterolemia, dyslipidemia, depression and stress. Median SHIM score was 13.9 (95%CI = 13.5-14.4) and 14.0 (95%CI = 13.6-14.4) for the Rx and the Non-Rx group, respectively (p=0.7892). In the Non-Rx group, 85.1% of men asked for a PDE5 inhibitor and the remaining men asked for herbal remedies, food supplements or vitamins. Patients of both groups take about 25 months since the first symptoms until they present with a healthcare professional. In the Non-Rx group 60,2% stated that this visit in the pharmacy was the first time they had spoken with a Healthcare Professional about their erection problems. CONCLUSIONS: Men without a prescription for ED treatment have the same degree of ED and an equal co-morbidity profile as men who have a prescription for a PDE5 inhibitor. Therefore community pharmacists should be actively trained on this condition as they may play a relevant role by educating men about ED and encouraging them to seek further medical care, because ED might be a sign of underlying conditions.

Conference/Value in Health Info

2009-10, ISPOR Europe 2009, Paris, France

Value in Health, Vol. 12, No. 7 (October 2009)

Code

PIH42

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Health Care Research

Disease

Pediatrics, Reproductive and Sexual Health, Urinary/Kidney Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×